As mentioned above, human cancer patients with TI PD-1+CD28−CD8+ T cells show resistance to PD-1 therapy (Kamphorst et al., 2017b; Hui et al., 2017; Kim et al., 2021). This evidence concerns the gene PDCD1 and cancer.